美国尿道狭窄疾病管理差异显著:AUA质量登记数据
基于AUA质量登记2014-2018年数据,20,640例接受手术治疗的男性尿道狭窄患者中,97.9%接受内镜治疗,31%接受重复内镜治疗,仅2.6%行尿道成形术;重复内镜治疗存在实践层面显著差异,且与患者高龄、膀胱癌诊断及医生年龄较高相关,提示内镜治疗过度使用且常与指南不一致。
要点
- 尿道狭窄手术治疗中内镜治疗占97.9%,尿道成形术仅2.6%。
- 31%患者接受重复内镜治疗,实践间差异显著。
- 高龄、膀胱癌诊断及医生年龄较高与重复内镜治疗几率增加相关。
核心结论
- 尿道狭窄疾病重复内镜治疗过度使用,且实践间差异显著、常与指南不一致,存在质量改进机会。
研究设计与样本
- 基于AUA质量(AQUA)登记2014-2018年前瞻性收集的数据,纳入20,640例接受手术治疗的男性尿道狭窄患者,涉及1,343名医生、171家实践机构,95%为社区为基础。
- 使用CPT和ICD-9/-10编码识别尿道狭窄手术,采用广义线性模型评估患者和医生因素与重复内镜治疗的关联。
主要发现
- 20,101例(97.9%)接受内镜治疗,6,218例(31%)在研究期间接受重复内镜治疗,539例(2.6%)接受尿道成形术。
- 内镜手术与尿道成形术患者首次手术中位年龄分别为73岁和39岁(p<0.001)。
- 实践层面重复内镜治疗率存在显著差异。
- 年龄≥80岁患者重复内镜治疗几率更高(OR=1.08,95%CI:1.06-1.11)。
- 有膀胱癌诊断的患者重复内镜治疗几率更高(OR=1.17,95%CI:1.15-1.20);医生年龄≥64岁亦与重复内镜治疗几率增加相关(OR=1.13,95%CI:1.11-1.16)。
临床怎么用
- 临床应关注尿道狭窄内镜治疗的过度使用,尤其对高龄、合并膀胱癌及由高龄医生诊治的患者,需评估重复内镜治疗的合理性并考虑尿道成形术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the degree of contemporary practice variation for the treatment of urethral stricture disease (USD) given repeated endoscopic management yields poor long-term success. MATERIALS AND METHODS: The AUA Quality (AQUA) Registry collects data from participating urologists across practice settings by direct interface with local electronic health record systems. We identified procedures used for USD using Current Procedural Terminology (CPT) and International Statistical Classification of Diseases (ICD-9/-10) codes. We assessed the association between patient and provider factors and repeated endoscopic treatment using generalized linear models. Provider details were derived from AUA Census. RESULTS: We identified 20,640 male patients with USD treated surgically in AQUA from 2014-2018. The patients were cared for by 1343 providers at 171 practices, 95% of these community-based. Among patients with USD who had treatment, 20,101(97.9%) underwent endoscopic management. 6218(31%) underwent repeated endoscopic treatment during the study period. Urethroplasty was performed in 539(2.6%) patients. Median patient age at first procedure for endoscopic surgery vs. urethroplasty was 73 vs. 39 years old, respectively (p<0.001). At the practice level, significant variation in rates of repeated endoscopic management was noted. Patients of older age (OR=1.08, 95%CI: 1.06-1.11 for ages ≥80) and patients with a bladder cancer diagnosis (OR=1.17, 95%CI: 1.15-1.20) had higher odds of receiving repeated endoscopic management. Increasing practitioner age was also associated with increased odds of repeated endoscopic management. (OR=1.13, 95%CI: 1.11- 1.16, for practitioners ≥64). CONCLUSIONS: Repeated endoscopic management for USD is overused. The utilization of endoscopic management is variable across practices and frequently guideline-discordant, presenting an opportunity for quality improvement.
引用
- Cohen AJ, Agochukwu-Mmonu N, Makarov DV, et al. Significant Management Variability of Urethral stricture Disease in United States: Data from the AUA Quality (AQUA) Registry. Urology. 2020. PMID: 32777368. doi:10.1016/j.urology.2020.07.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。